Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal congestion and allergic rhinitis; and REVTx-200, a nonclinical stage product for intranasal therapy. It is also involved in developing REVTx-300, a non-clinical stage product that is being developed as a …
Over the last 12 months, insiders at Revelation Biosciences, Inc. have bought $0 and sold $0 worth of Revelation Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Revelation Biosciences, Inc. have bought $151,908 and sold $2.26M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $29,000 was made by TIDMARSH GEORGE F (director) on 2023‑04‑18.
2023-12-08 | Sale | TIDMARSH GEORGE F | director | 27,771 0.4059% | $0.52 | $14,438 | -88.48% | |
2023-10-16 | Sale | TIDMARSH GEORGE F | director | 12,802 0.1963% | $0.66 | $8,442 | -88.31% | |
2023-09-28 | Sale | TIDMARSH GEORGE F | director | 1,429 0.0232% | $0.69 | $986 | -88.01% | |
2023-09-18 | Sale | TIDMARSH GEORGE F | director | 4,000 0.0648% | $0.74 | $2,960 | -88.05% | |
2023-09-15 | Sale | TIDMARSH GEORGE F | director | 9,500 0.1449% | $0.73 | $6,935 | -88.60% | |
2023-09-14 | Sale | TIDMARSH GEORGE F | director | 12,000 0.1906% | $0.75 | $9,000 | -88.44% | |
2023-04-18 | TIDMARSH GEORGE F | director | 25,000 1.1925% | $1.16 | $29,000 | -38.61% | ||
2023-04-17 | TIDMARSH GEORGE F | director | 26,500 1.1885% | $1.16 | $30,740 | -42.25% | ||
2022-02-25 | TIDMARSH GEORGE F | 20,000 0.1609% | $1.60 | $32,000 | -70.03% | |||
2022-02-09 | TIDMARSH GEORGE F | 30,000 0.2157% | $2.55 | $76,599 | -81.48% | |||
2022-02-08 | TIDMARSH GEORGE F | 1,000 0.007% | $2.54 | $2,540 | -81.68% | |||
2022-02-07 | TIDMARSH GEORGE F | 42,100 0.2939% | $2.61 | $109,780 | -82.13% | |||
2022-02-04 | TIDMARSH GEORGE F | 9,900 0.0679% | $2.34 | $23,156 | -80.31% | |||
2021-09-23 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 611,541 4.7291% | $10.08 | $6.16M | -88.63% | |
2021-09-22 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 5 <0.0001% | $10.08 | $50 | -88.58% | |
2021-09-21 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 43,000 0.3323% | $10.08 | $433,440 | -88.59% | |
2020-11-09 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 5,000 0.0396% | $10.00 | $50,000 | +1388373.68% | |
2020-10-12 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 20 0.0002% | $10.00 | $200 | +1386811.84% | |
2020-10-09 | Sale | GLAZER CAPITAL, LLC | 10 percent owner | 9,328 0.0738% | $10.00 | $93,280 | +1386314.47% |
Increased Positions | 6 | +75% | 5,940 | +95.99% |
Decreased Positions | 4 | -50% | 6,028 | -97.41% |
New Positions | 5 | New | 5,926 | New |
Sold Out Positions | 3 | Sold Out | 6,027 | Sold Out |
Total Postitions | 10 | +25% | 6,100 | -1.42% |
Xtx Topco Ltd | $11.00 | 0.31% | 3,115 | +3,115 | New | 2024-12-31 |
Two Sigma Securities, Llc | $6.00 | 0.18% | 1,819 | +1,819 | New | 2024-12-31 |
Geode Capital Management, Llc | $2.00 | 0.07% | 685 | +685 | New | 2024-12-31 |
Sbi Securities Co., Ltd. | $1.00 | 0.03% | 301 | +301 | New | 2024-12-31 |
Tower Research Capital Llc (Trc) | $1.00 | 0.02% | 158 | <1 | -0.63% | 2024-12-31 |
Bank Of America Corp /De/ | $0 | <0.01% | 16 | +14 | +700% | 2024-12-31 |
Royal Bank Of Canada | $0 | <0.01% | 6 | +6 | New | 2024-12-31 |
Ubs Group Ag | $0 | 0% | 0 | -2,559 | Sold Out | 2024-12-31 |
Sabby Management, Llc | $0 | 0% | 0 | -2,639 | Sold Out | 2024-12-31 |
Susquehanna International Group, Llp | $0 | 0% | 0 | -829 | Sold Out | 2024-12-31 |